News Articles and Montana BioScience Alliance Newsletters

A team of Montana researchers is playing a key role in the development of a more effective vaccine against tuberculosis, an infectious disease that has killed more people than any other.

University of Montana researchers and their partners have found a new method to generate human cartilage of the head and neck.

Microbion Corporation today announced that the company has published results from its topical pravibismane Phase 1b study in the peer-reviewed International Wound Journal.

A message from Scott Whittenburg, UM Vice President for Research and Creative Scholarship: “I’m happy to report that the research enterprise at UM continues to grow.”

Montana State University will send 17 students to one of the country’s premier celebrations of undergraduate research next week, where they will have the opportunity to present the research they have done in departments across the university. The National Conference on Undergraduate Research, or NCUR, will be held April 8-10 in Long Beach, California, and will feature undergraduate researchers from institutions nationwide.

When her husband was undergoing cancer treatment, Cindy Perez of Southwest Ranches, Fla., learned about a new blood test that could help find early cancers. The 50-year-old said she felt fine, but her husband urged her to take the test anyway.

Studies of interactions between two lab-generated monoclonal antibodies (mAbs) and an essential Epstein-Barr virus (EBV) protein have uncovered targets that could be exploited in designing treatments and vaccines for this extremely common virus.

As a new year begins in Congress, the Biotechnology Innovation Organization (BIO) is carrying over many of its legislative priorities from last year.

Administrative Supplements to Promote Diversity in Research and Development Small Businesses – SBIR/STTR

Contract Pre-solicitation for R&D that will contribute toward ARPA-H mission needs and SBIR program objectives.

View the December BIOWire Newsletter now!

View the September 2024 Newsletter now!